Cohen Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Sell |
7,004
-291
| -4% | -$20.3K | 0.26% | 54 |
|
|
2025
Q1 | $536K | Buy |
7,295
+65
| +0.9% | +$4.78K | 0.31% | 51 |
|
|
2024
Q4 | $474K | Buy |
7,230
+261
| +4% | +$17.1K | 0.29% | 56 |
|
|
2024
Q3 | $543K | Sell |
6,969
-1,554
| -18% | -$121K | 0.33% | 49 |
|
|
2024
Q2 | $577K | Buy |
8,523
+919
| +12% | +$62.2K | 0.46% | 46 |
|
|
2024
Q1 | $515K | Sell |
7,604
-282
| -4% | -$19.1K | 0.33% | 50 |
|
|
2023
Q4 | $531K | Sell |
7,886
-637
| -7% | -$42.9K | 0.39% | 49 |
|
|
2023
Q3 | $577K | Sell |
8,523
-608
| -7% | -$41.2K | 0.46% | 46 |
|
|
2023
Q2 | $654K | Sell |
9,131
-1
| -0% | -$72 | 0.53% | 45 |
|
|
2023
Q1 | $634K | Sell |
9,132
-69
| -0.7% | -$4.79K | 0.5% | 46 |
|
|
2022
Q4 | $624K | Buy |
9,201
+312
| +4% | +$21.2K | 0.52% | 45 |
|
|
2022
Q3 | $487K | Sell |
8,889
-489
| -5% | -$26.8K | 0.45% | 49 |
|
|
2022
Q2 | $620K | Sell |
9,378
-116
| -1% | -$7.67K | 0.53% | 44 |
|
|
2022
Q1 | $630K | Buy |
9,494
+92
| +1% | +$6.11K | 0.47% | 47 |
|
|
2021
Q4 | $548K | Sell |
9,402
-8
| -0.1% | -$466 | 0.39% | 50 |
|
|
2021
Q3 | $565K | Buy |
9,410
+32
| +0.3% | +$1.92K | 0.43% | 47 |
|
|
2021
Q2 | $562K | Buy |
9,378
+40
| +0.4% | +$2.4K | 0.44% | 45 |
|
|
2021
Q1 | $464K | Sell |
9,338
-84
| -0.9% | -$4.17K | 0.38% | 49 |
|
|
2020
Q4 | $471K | Buy |
+9,422
| New | +$471K | 0.43% | 47 |
|